FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048540138> ?p ?o ?g. }

• W2048540138 endingPage "e616" @default.
• W2048540138 startingPage "e616" @default.
• W2048540138 abstract "Cystic Echinococosis (CE) is a zoonotic disease caused by larval stage Echinococcus granulosus. We determined the effects of high dose of Oxfendazole (OXF), combination Oxfendazole/Praziquantel (PZQ), and combination Albendazole (ABZ)/Praziquantel against CE in sheep.A randomized placebo-controlled trial was carried out on 118 randomly selected ewes. They were randomly assigned to one of the following groups: 1) placebo; 2) OXF 60 mg/Kg of body weight (BW) weekly for four weeks; 3) ABZ 30 mg/Kg BW + PZQ 40 mg/Kg BW weekly for 6 weeks, and 4) OXF 30 mg/Kg BW+ PZQ 40 mg/Kg BW biweekly for 3 administrations (6 weeks). Percent protoscolex (PSC) viability was evaluated using a 0.1% aqueous eosin vital stain for each cyst. Noninfective sheep were those that had no viable PSCs; low-medium infective were those that had 1% to 60% PSC viability; and high infective were those with more than 60% PSC viability. We evaluated 92 of the 118 sheep. ABZ/PZQ led the lowest PSC viability for lung cysts (12.7%), while OXF/PZQ did so for liver cysts (13.5%). The percentage of either noninfective or low-medium infective sheep was 90%, 93.8% and 88.9% for OXF, ABZ/PZQ and OXF/PZQ group as compared to 50% noninfective or low-medium infective for placebo. After performing all necropsies, CE prevalence in the flock of sheep was 95.7% (88/92) with a total number of 1094 cysts (12.4 cysts/animal). On average, the two-drug-combination groups resulted pulmonary cysts that were 6 mm smaller and hepatic cysts that were 4.2 mm smaller than placebo (p<0.05).We demonstrate that Oxfendazole at 60 mg, combination Oxfendazole/Praziquantel and combination Albendazole/Praziquantel are successful schemas that can be added to control measures in animals and merits further study for the treatment of animal CE. Further investigations on different schedules of monotherapy or combined chemotherapy are needed, as well as studies to evaluate the safety and efficacy of Oxfendazole in humans." @default.
• W2048540138 created "2016-06-24" @default.
• W2048540138 creator A5001998738 @default.
• W2048540138 creator A5006489317 @default.
• W2048540138 creator A5019854695 @default.
• W2048540138 creator A5040912618 @default.
• W2048540138 creator A5042463464 @default.
• W2048540138 creator A5054457004 @default.
• W2048540138 creator A5057026285 @default.
• W2048540138 creator A5091655143 @default.
• W2048540138 date "2010-02-23" @default.
• W2048540138 modified "2023-10-02" @default.
• W2048540138 title "Evaluation of Oxfendazole, Praziquantel and Albendazole against Cystic Echinococcosis: A Randomized Clinical Trial in Naturally Infected Sheep" @default.
• W2048540138 cites W1969424075 @default.
• W2048540138 cites W1983325354 @default.
• W2048540138 cites W2002212525 @default.
• W2048540138 cites W2007322724 @default.
• W2048540138 cites W2011106429 @default.
• W2048540138 cites W2011440671 @default.
• W2048540138 cites W2018597228 @default.
• W2048540138 cites W2032414605 @default.
• W2048540138 cites W2037501160 @default.
• W2048540138 cites W2040433158 @default.
• W2048540138 cites W2056089364 @default.
• W2048540138 cites W2056096108 @default.
• W2048540138 cites W2056248153 @default.
• W2048540138 cites W2057515964 @default.
• W2048540138 cites W2061189349 @default.
• W2048540138 cites W2067671648 @default.
• W2048540138 cites W2072721273 @default.
• W2048540138 cites W2076996108 @default.
• W2048540138 cites W2079270012 @default.
• W2048540138 cites W2082238057 @default.
• W2048540138 cites W2089303444 @default.
• W2048540138 cites W2091149072 @default.
• W2048540138 cites W2094209655 @default.
• W2048540138 cites W2103534745 @default.
• W2048540138 cites W2107191207 @default.
• W2048540138 cites W2110666312 @default.
• W2048540138 cites W2124446832 @default.
• W2048540138 cites W2127509295 @default.
• W2048540138 cites W2127591583 @default.
• W2048540138 cites W4211173480 @default.
• W2048540138 cites W4251010516 @default.
• W2048540138 doi "https://doi.org/10.1371/journal.pntd.0000616" @default.
• W2048540138 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2826409" @default.
• W2048540138 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20186332" @default.
• W2048540138 hasPublicationYear "2010" @default.
• W2048540138 type Work @default.
• W2048540138 sameAs 2048540138 @default.
• W2048540138 citedByCount "31" @default.
• W2048540138 countsByYear W20485401382012 @default.
• W2048540138 countsByYear W20485401382013 @default.
• W2048540138 countsByYear W20485401382014 @default.
• W2048540138 countsByYear W20485401382015 @default.
• W2048540138 countsByYear W20485401382016 @default.
• W2048540138 countsByYear W20485401382017 @default.
• W2048540138 countsByYear W20485401382018 @default.
• W2048540138 countsByYear W20485401382021 @default.
• W2048540138 countsByYear W20485401382022 @default.
• W2048540138 countsByYear W20485401382023 @default.
• W2048540138 crossrefType "journal-article" @default.
• W2048540138 hasAuthorship W2048540138A5001998738 @default.
• W2048540138 hasAuthorship W2048540138A5006489317 @default.
• W2048540138 hasAuthorship W2048540138A5019854695 @default.
• W2048540138 hasAuthorship W2048540138A5040912618 @default.
• W2048540138 hasAuthorship W2048540138A5042463464 @default.
• W2048540138 hasAuthorship W2048540138A5054457004 @default.
• W2048540138 hasAuthorship W2048540138A5057026285 @default.
• W2048540138 hasAuthorship W2048540138A5091655143 @default.
• W2048540138 hasBestOaLocation W20485401381 @default.
• W2048540138 hasConcept C126322002 @default.
• W2048540138 hasConcept C141071460 @default.
• W2048540138 hasConcept C142724271 @default.
• W2048540138 hasConcept C165901193 @default.
• W2048540138 hasConcept C203014093 @default.
• W2048540138 hasConcept C204787440 @default.
• W2048540138 hasConcept C27081682 @default.
• W2048540138 hasConcept C2776225656 @default.
• W2048540138 hasConcept C2776715052 @default.
• W2048540138 hasConcept C2776908094 @default.
• W2048540138 hasConcept C2777028278 @default.
• W2048540138 hasConcept C2777065887 @default.
• W2048540138 hasConcept C2779687537 @default.
• W2048540138 hasConcept C2779744950 @default.
• W2048540138 hasConcept C2781348000 @default.
• W2048540138 hasConcept C2909003041 @default.
• W2048540138 hasConcept C42972112 @default.
• W2048540138 hasConcept C71924100 @default.
• W2048540138 hasConcept C86803240 @default.
• W2048540138 hasConcept C90856448 @default.
• W2048540138 hasConceptScore W2048540138C126322002 @default.
• W2048540138 hasConceptScore W2048540138C141071460 @default.
• W2048540138 hasConceptScore W2048540138C142724271 @default.
• W2048540138 hasConceptScore W2048540138C165901193 @default.
• W2048540138 hasConceptScore W2048540138C203014093 @default.
• W2048540138 hasConceptScore W2048540138C204787440 @default.
• W2048540138 hasConceptScore W2048540138C27081682 @default.

• next